Receptors, CCR2

"Receptors, CCR2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

CCR receptors with specificity for CHEMOKINE CCL2 and several other CCL2-related chemokines. They are expressed at high levels in T-LYMPHOCYTES; B-LYMPHOCYTES; MACROPHAGES; BASOPHILS; and NK CELLS.

Descriptor ID	D054390
MeSH Number(s)	D12.776.543.750.695.160.150.200 D12.776.543.750.705.852.125.150.200
Concept/Terms	Receptors, CCR2 Receptors, CCR2 MCP-1 Receptor MCP 1 Receptor Receptor, MCP-1 MCP-1 Receptors MCP 1 Receptors Receptors, MCP-1 Monocyte Chemoattractant Protein 1 Receptor CCR2 Receptor Receptor, CCR2 CCR2 Receptors CC Chemokine Receptor 2 CD192 Antigens Antigens, CD192 CC Chemokine Receptor-2 Chemokine Receptor-2, CC Receptor-2, CC Chemokine CC Chemokine Receptors 2 CCR2a Receptor CCR2a Receptor Receptor, CCR2a MCP-1RA CCR-2A MCP-1 Receptor CCR 2A MCP 1 Receptor MCP-1 Receptor, CCR-2A Receptor, CCR-2A MCP-1 MCP-1 Receptor CCR-2A MCP 1 Receptor CCR 2A Receptor CCR-2A, MCP-1 CCR2b Receptor CCR2b Receptor Receptor, CCR2b MCP-1 Receptor 2B MCP 1 Receptor 2B CCR2b Receptors Receptors, CCR2b CC CKR2B MCP-1RB

Below are MeSH descriptors whose meaning is more general than "Receptors, CCR2".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, G-Protein-Coupled [D12.776.543.750.695]
Receptors, Chemokine [D12.776.543.750.695.160]
Receptors, CCR [D12.776.543.750.695.160.150]
Receptors, CCR2 [D12.776.543.750.695.160.150.200]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Chemokine [D12.776.543.750.705.852.125]
Receptors, CCR [D12.776.543.750.705.852.125.150]
Receptors, CCR2 [D12.776.543.750.705.852.125.150.200]

Below are MeSH descriptors whose meaning is related to "Receptors, CCR2".

Below are MeSH descriptors whose meaning is more specific than "Receptors, CCR2".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, CCR2" by people in this website by year, and whether "Receptors, CCR2" was a major or minor topic of these publications.

Bar chart showing 13 publications over 10 distinct years, with a maximum of 2 publications in 2005 and 2018 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	0	1	1
2005	0	2	2
2008	1	0	1
2010	1	0	1
2011	1	0	1
2012	0	1	1
2013	1	0	1
2015	0	1	1
2018	1	1	2
2020	2	0	2

Below are the most recent publications written about "Receptors, CCR2" by people in Profiles.

Hao Q, Vadgama JV, Wang P. CCL2/CCR2 signaling in cancer pathogenesis. Cell Commun Signal. 2020 05 29; 18(1):82.

View in: PubMed
Bowler S, Siriwardhana C, Mitchell BI, D'Antoni ML, Ogata-Arakaki D, Souza S, Yee R, Gangcuangco LMA, Chow DC, Ndhlovu LC, Shikuma C. Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy. HIV Res Clin Pract. 2019 Aug - Oct; 20(4-5):123-129.

View in: PubMed
D'Antoni ML, Paul RH, Mitchell BI, Kohorn L, Fischer L, Lefebvre E, Seyedkazemi S, Nakamoto BK, Walker M, Kallianpur KJ, Ogata-Arakaki D, Ndhlovu LC, Shikuma C. Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism. J Acquir Immune Defic Syndr. 2018 09 01; 79(1):108-116.

View in: PubMed
D'Antoni ML, Mitchell BI, McCurdy S, Byron MM, Ogata-Arakaki D, Chow D, Mehta NN, Boisvert WA, Lefebvre E, Shikuma CM, Ndhlovu LC, Baumer Y. Cenicriviroc inhibits trans-endothelial passage of monocytes and is associated with impaired E-selectin expression. J Leukoc Biol. 2018 12; 104(6):1241-1252.

View in: PubMed
Ndhlovu LC, D'Antoni ML, Ananworanich J, Byron MM, Chalermchai T, Sithinamsuwan P, Tipsuk S, Ho E, Slike BM, Schuetz A, Zhang G, Agsalda-Garcia M, Shiramizu B, Shikuma CM, Valcour V. Loss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-na?ve HIV-infected Thais. J Neuroimmunol. 2015 Nov 15; 288:25-33.

View in: PubMed
Jalbert E, Shikuma CM, Ndhlovu LC, Barbour JD. Sequential staining improves detection of CCR2 and CX3CR1 on monocytes when simultaneously evaluating CCR5 by multicolor flow cytometry. Cytometry A. 2013 Mar; 83(3):280-6.

View in: PubMed
Nakasone ES, Askautrud HA, Kees T, Park JH, Plaks V, Ewald AJ, Fein M, Rasch MG, Tan YX, Qiu J, Park J, Sinha P, Bissell MJ, Frengen E, Werb Z, Egeblad M. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell. 2012 Apr 17; 21(4):488-503.

View in: PubMed
Mizutani M, Pino PA, Saederup N, Charo IF, Ransohoff RM, Cardona AE. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood. J Immunol. 2012 Jan 01; 188(1):29-36.

View in: PubMed
Saederup N, Cardona AE, Croft K, Mizutani M, Cotleur AC, Tsou CL, Ransohoff RM, Charo IF. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS One. 2010 Oct 27; 5(10):e13693.

View in: PubMed
Sako H, Miura S, Iwata A, Nishikawa H, Kawamura A, Matsuo K, Shirai K, Saku K. Changes in CCR2 chemokine receptor expression and plasma MCP-1 concentration after the implantation of bare metal stents versus sirolimus-eluting stents in patients with stable angina. Intern Med. 2008; 47(1):7-13.

View in: PubMed

People

Explore

Similar Concepts

Top Journals